Robotic versus laparoscopic Roux-en-Y gastric bypass: a propensity-matched comparison of the inflammatory response and MASLD trajectories. [PDF]
Tuffs C +11 more
europepmc +1 more source
Comparative effectiveness of first-line taxane-platinum versus fluorouracil-platinum chemotherapy in advanced esophageal squamous cell carcinoma: a propensity score-matched real-world study. [PDF]
Ye S, Li C, Liu R, Zhao C, Li J, Xu J.
europepmc +1 more source
The circadian clock gene CYCLE as a potential target for disrupting blood-feeding behavior in the mosquito Culex pipiens. [PDF]
Wijewardana C +11 more
europepmc +1 more source
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study. [PDF]
Siegerink SN +8 more
europepmc +1 more source
Response to Letter to the Editor: "Individuals Over 75-Year-Old Experience Greater Revisions Following Transforaminal Lumbar Interbody Fusion (TLIF): A Propensity Matched Study". [PDF]
Sharma M +3 more
europepmc +1 more source
Efficacy and safety of drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in unresectable gastric cancer with liver metastasis. [PDF]
Liu B +15 more
europepmc +1 more source
Thyroid autoantibodies predict long-term treatment response in euthyroid chronic spontaneous urticaria: a retrospective cohort study with propensity score matching. [PDF]
Zhuang L, Zhuang C, Jiang H, Su S.
europepmc +1 more source
Criminal Propensity and Personality Traits Among Adolescents: Analysing the Role of Psychoticism, Extraversion and Neuroticism. [PDF]
Dubey D +3 more
europepmc +1 more source
Effects of Isthmus Topography on the Molecular Characteristics of <i>BRAF</i>-mutant Papillary Thyroid Cancer. [PDF]
Kuo CY, Cheng SY, Hsu YC, Cheng SP.
europepmc +1 more source
Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study. [PDF]
Su Y +8 more
europepmc +1 more source

